Tumors of the Ear and Lateral Skull Base, Part 1
Preface Tu m o r s o f t h e E a r a n d La t e r a l Skull Base: Part I
George B. Wanna, MD, FACS Matthew L. Carlson, MD Editors
Over the past 100 years, the evaluation and management of lateral skull-base tumors have evolved tremendously. While most pathology involving the temporal bone and cerebellopontine angle is histologically benign, significant morbidity may occur as a result of disease progression or treatment. At the turn of the twentieth century, mortality from cerebellopontine angle tumor extirpation exceeded 80% and invariably resulted in substantial cranial nerve morbidity in the small percentage of those that survived the perioperative window. As a result of refinements in diagnostic imaging, microsurgical techniques, and stereotactic radiation delivery, today disease and treatment-associated mortality approaches zero and the majority of patients receive durable tumor control and experience minimal neurologic morbidity. Recognizing the significant advantages of multidisciplinary care, most centers utilize the collective expertise of neurotologists, neurosurgeons, and radiation oncologists in the treatment of patients with lateral skull-base tumors. It is a great honor and privilege to guest edit this important two-part issue of Otolaryngologic Clinics of North America titled “Tumors of the Ear and Lateral Skull Base.” We were extremely fortunate to assemble a cadre of world-renowned experts to share their clinical insights and knowledge regarding the complex and evolving treatment of lateral skull-base disease. Part 1 is primarily dedicated to temporal bone tumors, covering innovative imaging techniques, external auditory canal malignancy, glomus tympanicum, adenomatous tumors of the middle ear, endolymphatic sac tumors, glomus jugulare, jugular foramen meningioma and schwannoma, cholesterol granuloma, and pediatric temporal bone malignancies. We extend our sincerest gratitude to each
Otolaryngol Clin N Am 48 (2015) xiii–xiv http://dx.doi.org/10.1016/j.otc.2015.01.001 0030-6665/15/$ – see front matter Ó 2015 Published by Elsevier Inc.
oto.theclinics.com
xiv
Preface
contributing author for dedicating a significant amount of time and effort towards the completion of this comprehensive two-part issue. George B. Wanna, MD, FACS Division of Otology–Neurotology & Skull Base Surgery Neurotology Fellowship Program The Otology Group of Vanderbilt Vanderbilt University Medical Center 1215 21st Avenue South 7209 Medical Center East, South Tower Nashville, TN 37232, USA Matthew L. Carlson, MD Division of Otology–Neurotology & Skull Base Surgery Mayo Clinic Gonda Building, 12S-ENT 200 First Street Rochester, MN 55905, USA E-mail addresses: [email protected] (G.B. Wanna) [email protected] (M.L. Carlson)
Preface Tu m o r s o f t h e E a r a n d La t e r a l Skull Base: Part I
George B. Wanna, MD, FACS Matthew L. Carlson, MD Editors
Over the past 100 years, the evaluation and management of lateral skull-base tumors have evolved tremendously. While most pathology involving the temporal bone and cerebellopontine angle is histologically benign, significant morbidity may occur as a result of disease progression or treatment. At the turn of the twentieth century, mortality from cerebellopontine angle tumor extirpation exceeded 80% and invariably resulted in substantial cranial nerve morbidity in the small percentage of those that survived the perioperative window. As a result of refinements in diagnostic imaging, microsurgical techniques, and stereotactic radiation delivery, today disease and treatment-associated mortality approaches zero and the majority of patients receive durable tumor control and experience minimal neurologic morbidity. Recognizing the significant advantages of multidisciplinary care, most centers utilize the collective expertise of neurotologists, neurosurgeons, and radiation oncologists in the treatment of patients with lateral skull-base tumors. It is a great honor and privilege to guest edit this important two-part issue of Otolaryngologic Clinics of North America titled “Tumors of the Ear and Lateral Skull Base.” We were extremely fortunate to assemble a cadre of world-renowned experts to share their clinical insights and knowledge regarding the complex and evolving treatment of lateral skull-base disease. Part 1 is primarily dedicated to temporal bone tumors, covering innovative imaging techniques, external auditory canal malignancy, glomus tympanicum, adenomatous tumors of the middle ear, endolymphatic sac tumors, glomus jugulare, jugular foramen meningioma and schwannoma, cholesterol granuloma, and pediatric temporal bone malignancies. We extend our sincerest gratitude to each
Otolaryngol Clin N Am 48 (2015) xiii–xiv http://dx.doi.org/10.1016/j.otc.2015.01.001 0030-6665/15/$ – see front matter Ó 2015 Published by Elsevier Inc.
oto.theclinics.com
xiv
Preface
contributing author for dedicating a significant amount of time and effort towards the completion of this comprehensive two-part issue. George B. Wanna, MD, FACS Division of Otology–Neurotology & Skull Base Surgery Neurotology Fellowship Program The Otology Group of Vanderbilt Vanderbilt University Medical Center 1215 21st Avenue South 7209 Medical Center East, South Tower Nashville, TN 37232, USA Matthew L. Carlson, MD Division of Otology–Neurotology & Skull Base Surgery Mayo Clinic Gonda Building, 12S-ENT 200 First Street Rochester, MN 55905, USA E-mail addresses: [email protected] (G.B. Wanna) [email protected] (M.L. Carlson)
